
The market’s having a SaaS meltdown. Axon didn’t get the memo.
Axon is being framed as the antidote to the current “everything software is getting judged like a hotel minibar” vibe. In plain English: one analyst slapped a Buy rating and a $515 price target on the stock, arguing there’s still room to run even after the recent selloff in high-multiple names.
Why bulls are still circling
The pitch here is that Axon isn’t just another enterprise software story trying to survive the AI era. It’s a hardware-software combo with regulatory gravity and a pretty sticky ecosystem — the kind of setup that makes customers less likely to ghost you after one budget meeting.
The article points to a few metrics that matter:
- Q1 2026 revenue grew 34%
- AI product growth was up 700%+
- Counter-drone growth topped 300%+
- Net revenue retention hit 125%
That’s the sort of numbers cocktail that tells you the business isn’t wobbling just because the market is in a mood.
Why investors should care
The main debate is valuation versus durability. If you think the market’s punishing all software the same way, Axon starts to look like a bargain hidden inside the wreckage. If you think premium multiples still need premium proof, then you’re staring at the classic growth-stock knife fight.
Big picture: Axon’s story is basically, “we’re not a boring SaaS checkbox.” And in a selloff that’s been smashing a lot of software names into the same bucket, that distinction might be worth real money.
